ClusterOS Diagnostic Profile
London Life Sciences Health
London Life Sciences Health runs on 110 evidence items (London Life Sciences Health UKRI grants: 1958 grants, £1709m total, 248 disti). The diagnostic resolves a Extraction-Narrative configuration at MEDIUM confidence.
Value extraction events generate narrative about ecosystem success; narrative legitimises continued extraction by framing it as ecosystem contribution; uncertainty about whether extraction is harmful absorbed by the success narrative.
"A probe could test whether London & Partners or BIA (industry promotion bodies) reporting separately on value extraction (equity capital destinations, acquirer geographies, talent outflows) and value retention (licensing revenue to anchor institutions, follow-on collaborations, talent circulation) might perturb the extraction-narrative configuration by making attribution...
Leverage hypotheses are testable perturbations, not prescriptions. Where demand-side behaviour is weakly visible, the correct move is observation — improving visibility before attempting change.
A full ClusterOS diagnostic adds actor questionnaire data, working sessions, and anchor interviews — producing higher-confidence stall identification, board-ready stack analysis, and leverage hypotheses calibrated to your specific context.